PepGen

PEPGNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$206.393 M

$2.98 +4.93%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$89.7M

Loss-making

Shares outstanding

69,259,517

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#263AdageneADAG$213.3M
#264NkartaNKTX$211.3M
#265PepGenPEPG$206.4M
#266Journey MedicalDERM$204.6M
#267Sol-Gel TechnologiesSLGL$199.6M

What if PepGen were worth as much as…

Open the what-if tool →

Gold $30.2T

$436,531.63

Per share 146,487× higher

Bitcoin $1.74T

$25,146.80

Per share 8,439× higher

Nvidia $5.52T

$79,639.12

Per share 26,725× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for PepGen are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.